We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

bioMérieux

Designs, develops, manufactures and markets in vitro diagnostics systems used in clinical and industrial applications read more Featured Products: More products

Download Mobile App





bioMérieux Showcases State-Of-The-Art Data and Connectivity Tools

By LabMedica International staff writers
Posted on 03 Feb 2025
Print article
Image: The VITEK® REVEAL™ rapid Antimicrobial Susceptibility Testing helps better manage bloodstream infections (Photo courtesy of bioMérieux)
Image: The VITEK® REVEAL™ rapid Antimicrobial Susceptibility Testing helps better manage bloodstream infections (Photo courtesy of bioMérieux)

bioMérieux (Marcy l'Etoile, France) is showcasing its latest innovations at Medlab Middle East 2025 that are designed to support the timely delivery of results for impacting patient therapy.

Stopping the spread of resistant organisms means ensuring patients get the right dose at the right time. bioMérieux offers a one-stop-shop to provide critical diagnostic results the length of the antimicrobial resistance (AMR) patient pathway from therapy initiation to optimization to discontinuation. At the 2025 edition of Medlab Middle East, bioMérieux is exhibiting the VITEK® MS PRIME new-generation mass spectrometry microbial identification system. VITEK® MS PRIME combines microbiology expertise with innovation, taking mass spectrometry to the next level by maximizing the impact of daily laboratory workflow for better patient care. Alongside, bioMérieux is presenting the newest addition to its Sepsis Solution, VITEK® REVEAL™ which offers rapid antimicrobial susceptibility testing (AST) results to effectively and efficiently manage bloodstream infections

bioMérieux is also showcasing its stackable benchtop automated immunoassay solution, VIDAS® KUBE™ that is designed to preserve everything labs appreciate about the VIDAS® Solution combined with advanced technology. VIDAS® KUBE™ is a truly flexible, cost-effective automated immunoassay solution providing fast results in complete confidence. VIDAS® KUBE™ adaptable automation helps labs be more productive, more accurate, and more innovative – all in one simplified platform. Scaling with ease, VIDAS® KUBE™ is a simple and reliable addition to evolving labs, offering smart innovations that are both time- and cost-saving.

bioMérieux is contributing to the fight against AMR by expanding syndromic testing technology outside traditional clinical laboratories to the point-of-care settings to provide patients with fast answers, while giving clinicians the information they need to make timely, targeted treatment decisions. Among its solutions are BIOFIRE® FIREWORKS™ and BIOFIRE® SPOTFIRE® Respiratory Panels for providing access to a centralized data management web portal to give users total insights and analytics into BIOFIRE® System performance, utilization, pathogen surveillance, workflow management, and more. Also featuring at the event is the BIOFIRE® SPOTFIRE® System, the latest advancement in molecular infectious disease diagnostics from bioMérieux, with all of its expertise and cutting-edge FILMARRAY® technology at the heart of the system design.

New
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Gold Member
Veterinary Hematology Analyzer
Exigo H400
New
Gold Member
LEISHMANIA Test
LEISHMANIA ELISA
New
DVT/PE Test
VIDAS D-DIMER EXCLUSION II

Print article

Channels

Molecular Diagnostics

view channel
Image: RT-QuIC Prion, CSF is the only definitive antemortem clinical test of its kind that doesn’t involve a brain biopsy (Photo courtesy of Mayo Clinic)

CSF Test Distinguishes Prion Disease from Other Causes of Rapidly Progressive Dementia

Rapidly progressive dementias are a category of dementia where patients experience a swift decline from the onset of symptoms to losing functional independence, typically within two years.... Read more

Immunology

view channel
Image: New insights into preterm infant immunity could inform care (Photo courtesy of 123RF)

New Test Measures Preterm Infant Immunity Using Only Two Drops of Blood

Preterm infants are particularly vulnerable due to their organs still undergoing development, which can lead to difficulties in breathing, eating, and regulating body temperature. This is especially true... Read more

Pathology

view channel
Image: The Results Manager System (Photo courtesy of QuidelOrtho)

Informatics Solution Elevates Laboratory Efficiency and Patient Care

QuidelOrtho Corporation (San Diego, CA, USA) has introduced the QuidelOrtho Results Manager System, a cutting-edge informatics solution designed to meet the increasing demands of modern laboratories.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.